Ticker > Company >

Zenotech Labs. share price

Zenotech Laboratories Ltd.

BSE: 532039 SECTOR: Pharmaceuticals & Drugs  29.2 K   73   3

44.75
+0.46 (1.04%)
BSE: 24 Jul 04:01 PM

Price Summary

Today's High

₹ 45.72

Today's Low

₹ 44.1

52 Week High

₹ 62

52 Week Low

₹ 33.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

273.11 Cr.

Enterprise Value

242.69 Cr.

No. of Shares

6.1 Cr.

P/E

0

P/B

2.87

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  15.59

CASH

30.42 Cr.

DEBT

0 Cr.

Promoter Holding

68.84 %

EPS (TTM)

₹  -0.18

Sales Growth

1.32%

ROE

-1.12 %

ROCE

4.38%

Profit Growth

-119.1 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1.32%
3 Year0.93%
5 Year14.21%

Profit Growth

1 Year-119.1%
3 Year-145.23%
5 Year2.25%

ROE%

1 Year-1.12%
3 Year4.83%
5 Year13.38%

ROCE %

1 Year4.38%
3 Year9.58%
5 Year12.48%

Debt/Equity

0

Price to Cash Flow

26.76

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

1.49884872974011

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 68.84 0.00
Mar 2026 68.84 0.00
Dec 2025 68.84 0.00
Sep 2025 68.84 0.00
Jun 2025 68.84 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 38.545412992006% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 67.9186 days.
  • Company has a healthy liquidity position with current ratio of 3.4039.
  • The company has a high promoter holding of 68.84%.

 Limitations

  • The company has shown a poor profit growth of -145.231674992466% for the Past 3 years.
  • The company has shown a poor revenue growth of 0.925840988409909% for the Past 3 years.
  • Company has a poor ROE of 4.83226666666667% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 12.13 9.64 11.24 12.85 9.88
Total Expenditure 7.66 7.18 8.95 8.59 9.71
Operating Profit 4.47 2.46 2.29 4.26 0.17
Other Income 0.49 0.59 0.7 0.42 0.6
Interest 0 0 0 0 0
Depreciation 1.73 1.77 1.78 1.8 1.76
Exceptional Items -0.05 0 0.05 -0.3 0.05
Profit Before Tax 3.19 1.28 1.26 2.59 -0.94
Tax 1.96 0.29 2.1 0.66 2.22
Profit After Tax 1.23 0.99 -0.84 1.93 -3.15
Adjusted EPS (Rs) 0.2 0.16 -0.14 0.32 -0.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 36.57 42.42 40.83 43.05 43.61
Total Expenditure 19.1 21.72 23.62 28.87 34.43
Operating Profit 17.46 20.7 17.22 14.18 9.19
Other Income 0.63 1.08 1.01 1.55 2.31
Interest 1.22 0.11 0 0 0
Depreciation 6.97 7.17 7.09 6.96 7.11
Exceptional Items 0 0 0 1.92 -0.2
Profit Before Tax 9.9 14.5 11.14 10.69 4.19
Tax -12.27 2.92 2.84 5.08 5.26
Net Profit 22.18 11.59 8.3 5.61 -1.07
Adjusted EPS (Rs.) 3.63 1.9 1.36 0.92 -0.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 61.03 61.03 61.03 61.03 61.03
Total Reserves 9.61 21.24 29.51 35.1 34.09
Borrowings 6 0 0 0 0
Other N/C liabilities -10.41 -7.36 -4.38 -1.63 3.98
Current liabilities 15.58 16.61 13.52 12.59 12.06
Total Liabilities 81.81 91.52 99.68 107.09 111.15
Assets
Net Block 70.91 65.38 65.58 60.87 62.29
Capital WIP 0.28 4.98 1.96 3.57 3.6
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 3.15 4.79 5.75 6.42 4.22
Other N/C Assets 0.1 0.1 0.23 0.24 0
Current Assets 7.37 16.26 26.16 35.99 41.04
Total Assets 81.81 91.52 99.68 107.09 111.15
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 9.9 14.5 11.14 10.69 4.19
Adjustment 8.01 6.86 6.17 3.63 5.6
Changes in Assets & Liabilities 0.76 0.49 -4.41 -2.89 -0.16
Tax Paid -1 -1.19 -1.07 -1.94 0.58
Operating Cash Flow 17.67 20.66 11.82 9.49 10.2
Investing Cash Flow -1.84 -5.82 -21.15 15.27 -6.49
Financing Cash Flow -15.87 -6.11 0 0 0
Net Cash Flow -0.04 8.73 -9.33 24.76 3.71

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 68.84 68.84 68.84 68.84 68.84
sun pharmaceutical indust... 68.84 68.84 68.84 68.84 68.84
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 31.16 31.16 31.16 31.16 31.16
dr. jayaram chigurupati 3.59 3.59 3.59 3.59 3.33
minal bharat patel 1.72 1.72 1.72 1.72 1.72
padmasree chigurupati 5.26 5.26 5.26 5.26 5.52
pat financial consultants... 3.98 3.98 3.98 3.98 3.98
zenotech llc 1.14 1.14 1.14 1.14 1.14

Annual Reports

Title Link
Title Link
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us

Zenotech Labs. Stock Price Analysis and Quick Research Report. Is Zenotech Labs. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Zenotech Labs.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zenotech Labs. has a PE ratio of -254.695503699488 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zenotech Labs. has ROA of -0.9825% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zenotech Labs. has a Current ratio of 3.4039.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zenotech Labs. has a ROE of -1.1211%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Zenotech Labs. has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Zenotech Labs. has reported revenue growth of 1.316% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Zenotech Labs. for the current financial year is 21.0679696241539%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zenotech Labs. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Zenotech Labs. is Rs -0.1757. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Zenotech Labs. in Ticker for free. Also, one can get the intrinsic value of Zenotech Labs. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Zenotech Labs. FAQs

Q1. What is Zenotech Labs. share price today?
Ans: The current share price of Zenotech Labs. is Rs 44.75.

Q2. What is the market capitalisation of Zenotech Labs.?
Ans: Zenotech Labs. has a market capitalisation of Rs 273.1117918 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Zenotech Labs.?
Ans: The PE ratio of Zenotech Labs. is -254.695503699488 and the P/B ratio of Zenotech Labs. is 2.87120327477576, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Zenotech Labs. share?
Ans: The 52-week high share price of Zenotech Labs. is Rs 62, and the 52-week low share price of Zenotech Labs. is Rs 33.55.

Q5. Does Zenotech Labs. pay dividends?
Ans: Currently, Zenotech Labs. does not pay dividends. Dividend yield of Zenotech Labs. is around 0%.

Q6. What are the face value and book value of Zenotech Labs. shares?
Ans: The face value of Zenotech Labs. shares is Rs 10, while the book value per share of Zenotech Labs. is around Rs 15.5858. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Zenotech Labs.?
Ans: Zenotech Labs. has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Zenotech Labs.?
Ans: The ROE of Zenotech Labs. is -1.1211% and ROCE of Zenotech Labs. is 4.3806%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Zenotech Labs. a good buy for the long term?
Ans: The Zenotech Labs. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Zenotech Labs. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Zenotech Labs. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Zenotech Labs.’s financials?
Ans: You can review Zenotech Labs.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Zenotech Labs.
X